Information
-
Document No.
-
Department
-
Conducted on
-
Prepared by
-
Personnel
Governance and systems for medication safety
-
4.1.1 Governance arrangements are in place to support the development, implementation and maintenance of organisation -wide medication safety systems
-
4.1.2 Policies, procedures and/or protocols are in place that are consistent with legislative requirements, national, jurisdictional and professional guidelines
-
4.2.1 The medication managment system is regularly assessed
-
4.2.2. Action is taken to reduce the risks identified in the medication management system
-
4.3.1 A system is in place to verify that the clinical workforce have medication authorities appropriate to their scope of practice
-
4.3.2 The use of the medication authorisation system is regularly monitored
-
4.3.3 Action is taken to increase the effectiveness of the medication management authority system
-
4.4.1 Medication incidents are regularly monitored, reported and investigated
-
4.4.2 Action is taken to reduce the risk of adverse medication incidents
-
4.5.1 The performance of the medication management system is regularly assessed
-
4.5.2 Quality improvement activities are undertaken to reduce the risk of patient harm and increase the quality and effectiveness of medicines use
Documentation of patient information
-
4.6.1 A best possible medication history is documented for each patient
-
4.6.2 The medication history and current clinical information is available at the point of care
-
4.7.1 Known medication allergies and adverse drug reactions are documented in the patient clinical record
-
4.7.2 Action is taken to reduce the risk of adverse reactions
-
4.7.3 Adverse drug reactions are reported within the organisation and to the Therapeutic Goods Administration
-
4.8.1 (D) Current medicines are documented and reconciled at admission and transfer of care between health settings
Medication management processes
-
4.9.1 Information and decision support tools for medicines are availalbe to the clinical workforce at the point of care
-
4.9.2 The use of the information and decision support tools are regularly reviewed
-
4.9.3 Action is taken to improve the availability and effectiveness of information and decision support tools
-
4.10.1 Risks associated with secure storage and safe distribution of medicines are regularly reviewed
-
4.10.2 Action is taken to reduce the risks associated with storage and distribution of medicines
-
4.10.3 The storage of temperature-sensitive medicines is monitored
-
4.10.4 A system that is consistent with legislative and jurisdictional requirements for the disposal of unused, unwanted or expired medications is in place
-
4.10.5 The system for disposal of unused, unwanted or expired medications is routinely monitored
-
4.10.6 Action is taken to increase compliance with the system for storage, distribution and disposal of medications
-
4.11.1 The risks for storing, prescribing, dispensing and administration of high-risk medicines are regularly reviewed
-
4.11.2 Action is taken to reduce the risks of storing, prescribing, dispensing and administering high-risk medicines
Continuity of medication management
-
4.12.1 A system is in use that generates and distributes a current and comprehensive list of medicines and explanation of changes in medicines
-
4.12.2 A current and comprehensive list of medicines is provided to the patient and/or carer when concluding an episode of care
-
4.12.3 A current comprehensive list of medicines is provided to the receiving clinician during clinical handover
-
4.12.4 Action is taken to increase the proportion of patients and receiving clinicians that are provided with a current comprehensive list of medicines during clinical handover
Communicating with patients and carers
-
4.13.1 (D) The clinical workforce provides patients with patient-specific medicine information, including medical treatment options, benefits and associated risks
-
4.13.2 (D) Information that is designed for distribution to patients is readily available to the clinical workforce
-
4.14.1 (D) An agreed medication management plan is documented and available in the patient's clinical record
-
4.15.1 (D) Information on medicines is provided to patients and carers in a format that is understood and meaningful
-
4.15.2 (D) Action is taken in response to patient feedback to improve medicines information distributed by the health service organisation to patients